Journal articleN Engl J Med2011
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
- Journal
- N Engl J Med
- Published
- 1 May 2011
- Citations
- 6,054
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 34
- Its registry lists this paper as resultsCombination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer NCT00112658↗
- BackgroundNALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer NCT07595172↗
- BackgroundUsing Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment NCT06574620↗
- BackgroundStereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and … NCT07173374↗
- BackgroundSystemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer NCT04276857↗
- BackgroundOnvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer NCT06736717↗
- BackgroundPancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX NCT06349278↗
- BackgroundEvaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line… NCT07243288↗
- BackgroundSintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer NCT06050317↗
- BackgroundClinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer NCT05840341↗
- BackgroundPancreatic Cancer Detection Consortium NCT06388967↗
- BackgroundNeoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer NCT05132504↗
- BackgroundLiquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) NCT05346536↗
- BackgroundEfficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients NCT05065801↗
- BackgroundThe First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients NCT05168527↗
- BackgroundExploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With … NCT04787991↗
- BackgroundConcurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer NCT05262452↗
- BackgroundSurvival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry… NCT04984174↗
- BackgroundPharmacotyping of Pancreatic Patient-derived Organoids NCT05196334↗
- BackgroundSequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With… NCT04570943↗
- BackgroundLiposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma NCT04662112↗
- BackgroundTAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma NCT04923529↗
- BackgroundFlouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN) NCT04769414↗
- BackgroundLiquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer NCT05400681↗
- Background1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma NCT04098081↗
- BackgroundA Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX NCT03450018↗
- BackgroundEvaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma NCT03717298↗
- BackgroundA Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer NCT03167112↗
- BackgroundProspectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis NCT02869802↗
- BackgroundNeoadjuvant Modified FOLFIRINOX in Borderline Resectable Pancreatic Cancer NCT02749136↗
- BackgroundAcelarin First Line Randomised Pancreatic Study NCT03610100↗
- BackgroundIntraoperative Radiation Therapy for Resectable Pancreas Cancer NCT02599662↗
- BackgroundGemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer NCT01488552↗
- BackgroundPancreatic Surgery in Elderly Patients NCT04893408↗
The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.